2017年重庆市巴南区35~75岁城市居民血脂水平分析

Analysis of Lipid Levels Among Urban Residents Aged35-75 in Banan District of Chongqing in 2017

目的分析重庆市巴南区35~75岁城市居民血脂异常的流行特征。方法按照分层随机抽样方法,2017年抽取重庆市巴南区4个城区街道年龄在35~75岁之间的居民11716名,开展问卷调查,同时采集被调查对象空腹静脉血6 ml,检测其总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C),分析血脂异常患病率与性别、年龄关系。率的比较运用SPSS 17.0统计软件进行χ^(2)检验。结果11716名调查对象,血脂异常总患病率为40.57%,其中男女性血脂异常患病率分别为37.57%和42.42%,女性高于男性,差异有统计学意义(χ^(2)=26.94,P<0.001);血脂TC、TG、HDL-C和LDL-C异常患病率分别为9.06%、19.87%、10.55%和3.18%;血脂异常总患病率呈先升后降低趋势,在60~64岁年龄组达最高值(47.13%)。结论重庆市巴南区35~75岁城市居民血脂异常水平较高,中老年女性是血脂异常的重点人群,应采取社区综合干预措施加强重点人群血脂异常防控,以降低动脉粥样硬化性心血管疾病的发病率和死亡率。

Objective To analyze the epidemiological characteristics of dyslipidemia among urban residents aged 35-75 years old in Banan district,Chongqing.Methods According to stratified random sampling method,11716 residents aged 35-75 were selected from four urban streets in Banan district,and a questionnaire survey was conducted.At the same time,6 ml of fasting venous blood was collected.Total cholesterol(TC),triglyceride,Low-density Lipoprotein(LDL-C)and high-density lipoprotein cholesterol(HDL-C)were measured and the prevalence of dyslipidemia was analyzed in relation to sex and age.Rates were compared by using SPSS 17.0 statistical software forχ^(2) test.Results The total prevalence rate of dyslipidemia was 40.57%in 11716 subjects.The prevalence rates of dyslipidemia in males and females were 37.57%and 42.42%respectively.The prevalence rates of dyslipidemia in females were higher than those in males,the differences were statistically significant(χ^(2)=26.94,P=0.00);The prevalence rates of TC,TG,HDL-C and LDLC were 9.06%,19.87%,10.55%and 3.18%respectively.The total prevalence of dyslipidemia increased first and then decreased,reaching the highest value(47.13%)in the 60 tp 64-year-old group.Conclusion The level of dyslipidemia in the city residents aged 35 to 75 in Banan district of Chongqing was higher,and the middle-aged and elderly women were the key group of dyslipidemia.Comprehensive community intervention measures should be taken to strengthen the prevention and control of dyslipidemia in the key group,so that to reduce the incidence and mortality of arteriosclerosis cardiovascular disease.